IL251049A0 - Systems and methods for terminating opioid-induced euphoria - Google Patents

Systems and methods for terminating opioid-induced euphoria

Info

Publication number
IL251049A0
IL251049A0 IL251049A IL25104917A IL251049A0 IL 251049 A0 IL251049 A0 IL 251049A0 IL 251049 A IL251049 A IL 251049A IL 25104917 A IL25104917 A IL 25104917A IL 251049 A0 IL251049 A0 IL 251049A0
Authority
IL
Israel
Prior art keywords
systems
methods
induced euphoria
opioid
attenuating
Prior art date
Application number
IL251049A
Other languages
English (en)
Hebrew (he)
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of IL251049A0 publication Critical patent/IL251049A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL251049A 2014-09-12 2017-03-09 Systems and methods for terminating opioid-induced euphoria IL251049A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462049989P 2014-09-12 2014-09-12
US201462065393P 2014-10-17 2014-10-17
PCT/US2015/049948 WO2016040934A1 (en) 2014-09-12 2015-09-14 Systems and methods for attenuating opioid-induced euphoria

Publications (1)

Publication Number Publication Date
IL251049A0 true IL251049A0 (en) 2017-04-30

Family

ID=55453711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL251049A IL251049A0 (en) 2014-09-12 2017-03-09 Systems and methods for terminating opioid-induced euphoria

Country Status (11)

Country Link
US (2) US20160074387A1 (enExample)
EP (1) EP3190890A4 (enExample)
JP (1) JP2017526719A (enExample)
KR (1) KR20170052644A (enExample)
CN (1) CN107072204A (enExample)
AU (1) AU2015314714A1 (enExample)
CA (1) CA2961009A1 (enExample)
IL (1) IL251049A0 (enExample)
MA (1) MA40333A (enExample)
TW (1) TW201613590A (enExample)
WO (1) WO2016040934A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
CA3068036A1 (en) * 2017-06-30 2019-01-03 Purdue Pharma L.P. Use to buprenorphine in combination with an opioid to treat pain
AU2018351502B2 (en) * 2017-10-20 2024-09-05 Purdue Pharma L.P. Pharmaceutical dosage forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1613266A4 (en) * 2003-04-15 2009-05-06 Theraquest Biosciences Llc METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
EP1813276A1 (en) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Tamper resistant dosage forms
US20090246265A1 (en) * 2008-03-26 2009-10-01 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
WO2011109743A2 (en) * 2010-03-04 2011-09-09 Rand Jerry N Synergistic effects of combinations of buprenorphine and opioids for the treatment of pain
CA2817071C (en) * 2010-11-08 2018-04-24 Omeros Corporation Treatment of addiction and impulse-control disorders using pde7 inhibitors
HK1206978A1 (en) * 2012-04-17 2016-01-22 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response

Also Published As

Publication number Publication date
WO2016040934A1 (en) 2016-03-17
JP2017526719A (ja) 2017-09-14
MA40333A (fr) 2016-03-17
AU2015314714A1 (en) 2017-03-09
KR20170052644A (ko) 2017-05-12
EP3190890A4 (en) 2018-04-25
EP3190890A1 (en) 2017-07-19
US20200276187A1 (en) 2020-09-03
US20160074387A1 (en) 2016-03-17
CA2961009A1 (en) 2016-03-17
CN107072204A (zh) 2017-08-18
TW201613590A (en) 2016-04-16

Similar Documents

Publication Publication Date Title
PL3822197T3 (pl) Systemy i sposoby do przetwarzania zamówienia
EP3229906C0 (en) SYSTEMS AND METHODS FOR OPTIMIZING TRANSCRANIAL ACOUSTIC TREATMENT
SG10201405182WA (en) Method and system
SG11201704316YA (en) Methods and apparatuses for haptic systems
ZA201504224B (en) Systems for delivering explosives and methods related thereto
EP3102289A4 (en) Systems and methods for phototherapy
EP3129100A4 (en) Electromagnetic therapy device and methods
HUE043458T2 (hu) Eljárások és rendszerek korai pozícionálási pont elõállítására
GB201316673D0 (en) Account association systems and methods
GB201704104D0 (en) Methods and systems for modelind an advanced 3-dimensional bottomhole assembly
GB201317311D0 (en) Account association systems and methods
GB201421814D0 (en) System and method
SG11201607836WA (en) Inspection methods and systems
SG10201500398VA (en) Systems and Methods for Creating and Evaluating Experiments
PL3171785T3 (pl) Urządzenie osłaniające i sposób osłaniania
SG11201609292QA (en) Panel systems and methods
SG11201604447QA (en) Systems and methods for reducing scouring
GB201405488D0 (en) Decaffeination methods and systems
PL3216016T3 (pl) System i sposób dla przebieralni
SG10201406639UA (en) Event Processing Systems and Methods
EP2974483A4 (en) SYSTEMS AND METHOD FOR APPROACHING GEOFENCING PLACES
EP2981339A4 (en) SYSTEMS AND METHOD FOR ADVANCED BETTING
IL251049A0 (en) Systems and methods for terminating opioid-induced euphoria
GB201404184D0 (en) Method and system
GB201523060D0 (en) Speed-limit-compliance system and method